ELISABETH PHARMACON, spol. s r. o. was founded in Brno, Czech Republic in 2001 by Czech biologist dr. Omar Šerý and businessman Mr. Petr Čermák. In its early days the company was known for research, development and producing DNA diagnostics under the brand name EliGene®.
ELISABETH PHARMACON cooperates with many research institutes and clinics. Since its beginnings, the company has been cooperating with the Faculty of Science, Masaryk University. In 2008, it became the first Czech company to produce DNA diagnostics under EN ISO 13485:2012 certification.
Since 2012 company has been developing and manufacturing laboratory devices, e.g. PCR workstations ZEPHYRUS®.
The quality systems EN ISO 13485:2012 and EN ISO 9001:2009 cover all activities such as designing, developing, manufacturing, purchasing, storage and selling of in-vitro diagnostic medical devices and molecular biology testing, measuring and analysis. The aim is to offer the best quality products at the best available price on the market.
By 2014, the company had invested more than 3,4 million EUR in laboratory instruments and the research. The company's research is continually supported by grant projects of the Investment and Business Development Agency (CzechInvest) and the Ministry of Industry and Business of the Czech Republic.
ELISABETH PHARMACON Ltd. was founded by Czech biologist Dr. Omar Sery and businessman Mr. Petr Cermak in London (2012). The company sales DNA diagnostics under the brand name EliGene® and biohazard boxes under the brand name Zephyrus.
Both companies are members of ELISABETH PHARMACON Group.